Display Settings:

Format

Send to:

Choose Destination
    Pharmacopsychiatry. 2011 May;44(3):96-101. Epub 2011 Feb 16.

    Impact of duration of antidepressant treatment on the risk of occurrence of a new sequence of antidepressant treatment.

    Source

    Université Bordeaux 2, Bordeaux, France. helene.verdoux@u-bordeaux2.fr

    Abstract

    INTRODUCTION:

    Despite the recommendation that antidepressant treatment should be continued for several months to reduce the risk of relapse/recurrence of depression, early discontinuation is frequent in naturalistic conditions. The study was aimed at exploring the impact of early discontinuation of antidepressant treatment on the risk of antidepressant re-initiation.

    METHODS:

    A follow-up study of persons (n=35,053) starting antidepressant treatment was performed using a representative sample of the French Social Security Insurance national database.

    RESULTS:

    The risk of re-initiation of antidepressant treatment was higher if the duration of the index episode of antidepressant treatment was ≥ 6 months [hazard ratio (HR)=2.35; 95% CI 2.25-2.45) or 2-5 months (HR=1.65; 95% CI 1.59-1.71) compared to ≤ 1 month. The other characteristics independently associated with re-initiation of treatment were older age, female gender, low income, serious chronic illness, index prescription by a specialist and co-prescription of other psychotropic drugs.

    CONCLUSIONS:

    The lower risk of re-initiation of antidepressant treatment in persons with shorter-than-recommended duration of antidepressant treatment might be explained by overprescription of antidepressants in persons with sub-threshold symptoms.

    © Georg Thieme Verlag KG Stuttgart · New York.

    PMID:
    21328195
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Click here to read

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk